Irdabisant
CAS: 1005402-19-6
Ref. TM-T32191
| 1mg | 96.00 € | ||
| 5mg | 213.00 € | ||
| 10mg | 325.00 € | ||
| 25mg | 547.00 € | ||
| 50mg | 785.00 € | ||
| 100mg | 1,077.00 € | ||
| 500mg | 2,164.00 € | ||
| 1ml*10 (DMSO) | 153.00 € |
Estimated delivery in United States, on Monday 13 May 2024
Product Information
Name:
Irdabisant
Synonyms:
- CEP-26401, CEP 26401, CEP26401
CAS:
Description:
Irdabisant (CEP-26401) (CEP-26401) is a selective, orally active and blood-brain barrier (BBB) penetrant antagonist/inverse agonist of histamine H3 receptor (H3R) (rat H3R Ki= 7.2 nM, human H3R Ki= 2.0 nM). Irdabisant exhibits relatively low inhibitory activity against hERG current (IC50= 13.8 μM). Irdabisant exhibits cognition-enhancing and wake-promoting activities in the rat social recognition model. Irdabisant can be used for research on schizophrenia or cognitive impairment.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
313.39
Formula:
C18H23N3O2
Purity:
99.77%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T32191 Irdabisant
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
